Advertisement
Screener

QT IMAGING HOLDINGS, INC. (QTI) Net Change in Cash

2.8 / 5 stars · 68/120 Roast Me

QT IMAGING HOLDINGS, INC. Net Change in Cash

QT IMAGING HOLDINGS, INC. (QTI) reported Net Change in Cash of $512.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-12

  • QT IMAGING HOLDINGS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was -$3.51M, a 293.39% decline year-over-year.
  • QT IMAGING HOLDINGS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $1.82M, a 66.71% decline year-over-year.
  • QT IMAGING HOLDINGS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $5.46M.
  • QT IMAGING HOLDINGS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$77.02K.
  • QT IMAGING HOLDINGS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was $9.27M, a 820.56% increase from fiscal 2024.
  • QT IMAGING HOLDINGS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $1.01M.
  • QT IMAGING HOLDINGS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$290.39K.
  • QT IMAGING HOLDINGS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$343.35K.
Period endCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month as first filedCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month as first filedCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month as first filedCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 11 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month as first filed
2026-06-30$512.00K
10-Q · filed 2026-08-12
2026-03-31-$3.51M
10-Q · filed 2026-05-13
2025-12-31$9.27M
10-K · filed 2026-03-25
2025-09-30$543.30K
10-Q · filed 2025-11-12
2025-06-30$850.00K
10-Q · filed 2026-08-12
$850.08K
10-Q · filed 2025-08-07
2025-03-31$1.82M
10-Q · filed 2026-05-13
$1.82M
10-Q · filed 2025-05-13
2024-12-31$1.01M
10-K · filed 2026-03-25
$1.01M
10-K · filed 2025-03-31
2024-09-30$1.38M
10-Q · filed 2025-11-12
2024-06-30$4.42M
10-Q · filed 2025-08-07
2024-03-31$5.46M
10-Q · filed 2025-05-13
2023-12-31-$290.39K
10-K · filed 2025-03-31
-$75.76K
10-K · filed 2024-03-25
2023-09-30-$420.59K
10-Q · filed 2024-11-13
$43.66K
10-Q · filed 2023-11-14
2023-06-30-$219.04K
10-Q · filed 2024-08-08
-$70.72K
10-Q · filed 2023-08-14
2023-03-31-$77.02K
10-Q · filed 2024-05-13
$277.94K
10-Q · filed 2023-05-15
2022-12-31-$343.35K
10-K · filed 2024-03-25
2022-09-30$64.11K
10-Q · filed 2023-11-14
2022-06-30-$366.39K
10-Q · filed 2023-08-14
2022-03-31-$229.45K
10-Q · filed 2023-05-15
2021-12-31$421.55K
10-K · filed 2023-03-31
2021-09-30$2.05M
10-Q · filed 2022-11-14
2021-06-30$45.21K
10-Q · filed 2022-08-15
2021-03-31$45.21K
10-Q · filed 2022-05-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Outset Medical, Inc. (OM)United States$0.059B-1.09
IRIDEX CORP (IRIX)United States$0.011B
ENDRA Life Sciences Inc. (NDRA)United States$0.009B
Nuwellis, Inc. (NUWE)United States$0.003B
Streamex Corp. (STEX)United States$0.089B-0.19
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B